Two New Solutions From DePuy Synthes Companies Go 'Beyond The Implant' For Orthopaedic Patients

LAS VEGAS, March 24, 2015 /PRNewswire/ -- DePuy Synthes Companies is offering health care professionals a new way to track and analyze patient data in real-time and a new program to improve patients' experience with joint replacement surgery. Both solutions are featured alongside the company's extensive portfolio of orthopaedic products and solutions at the 81^st annual meeting of the American Academy of Orthopaedic Surgeons (AAOS).  

DePuy Synthes Companies is offering a subscription-based service called CareSense, a software solution that enables health care providers and institutions to collect and analyze real-time data. With CareSense, patient outcomes, patient satisfaction and cost information can be collected and evaluated before, during and after surgery, to help optimize care. The system makes it easy to conduct market research, administer patient satisfaction surveys, benchmark against peers, and analyze financial metrics. CareSense, which is licensed from Medtrak Inc. by DePuy Synthes Joint Reconstruction*, is available globally through DePuy Synthes Companies that addresses specialties including joint reconstruction, trauma, spinal surgery and sports medicine.

While CareSense focuses on data collection and analysis, the video based PATIENT ATHLETE^™** Program helps joint replacement patients take their experience beyond pain reduction to learning how to bring their full and best energy to the people and things that matter most in their lives—both before and after their surgery. The program includes self-guided lessons that a patient views four weeks prior to surgery and eleven refresher lessons to complete post-surgery.  It provides patients with simple action steps and tools to help better equip them to understand how joint pain has affected all aspects of their lives, and helps them take steps to maximize their recovery. The PATIENT ATHLETE Program was piloted in three cities and a survey of these patients found that more than half of the patients felt they recovered more quickly and were less fearful of surgery because of the program. The program utilizes science-based tools and techniques developed by the Johnson & Johnson Human Performance Institute for training top athletes, surgeons, CEOs, and others looking to optimize their performance in work and life.

Both CareSense and the PATIENT ATHLETE Program are part of DEPUY SYNTHES ADVANTAGE™, which offers customized, measureable solutions that help achieve triple aim performance – improved outcomes, increased patient satisfaction, and reduced cost. 

"My team has had the opportunity to engage with DEPUY SYNTHES ADVANTAGE and gained great benefit from its many solutions," said James Van Horne, M.D., Paragon Orthopedic Center. "As device manufacturers such as DePuy Synthes work to partner with healthcare providers and physicians to achieve the Triple Aim, it is clear to me that programs such as DEPUY SYNTHES ADVANTAGE will play a critical role in this new healthcare environment."

To find out more about the DEPUY SYNTHES ADVANTAGE suite of solutions, visit www.depuysynthesadvantage.com.

DePuy Synthes Companies
DePuy Synthes Companies provides the most comprehensive orthopaedic and neurological solutions in the world. The company offers an unparalleled breadth of products, services, programs and research and development capabilities. DePuy Synthes Companies' solutions in the specialties of joint reconstruction, trauma, neurological, craniomaxillofacial, spinal surgery and sports medicine are designed to advance patient care while delivering clinical and economic value to health care systems worldwide. For more information, visit www.depuysynthes.com.

Note on Forward-Looking Statements
(This press release contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995. The reader is cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of DePuy Orthopaedics, Inc. and/or Johnson & Johnson. Risks and uncertainties include, but are not limited to: uncertainty of commercial success for new and existing products; the ability of the company to successfully execute strategic plans; competition, including technological advances, new products and patents attained by competitors; global health care reforms and trends toward health care cost containment; product recalls or regulatory action; and manufacturing difficulties and delays. A further list and description of these risks, uncertainties and other factors can be found in Johnson & Johnson's Annual Report on Form 10-K for the fiscal year ended December 28, 2014, including in Exhibit 99 thereto, and the company's subsequent filings with the Securities and Exchange Commission. Copies of these filings are available online at www.sec.gov, www.jnj.com or on request from Johnson & Johnson. Neither DePuy Orthopaedics, Inc. nor Johnson & Johnson undertake to update any forward-looking statement as a result of new information or future events or developments.)

*DePuy Synthes Joint Reconstruction is a division of DePuy Orthopaedics, Inc.
**Costs associated with this program
©DePuy Synthes 2015. All rights reserved.

DSUS/MOC/0315/0238

SOURCE DePuy Synthes Companies